Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 23;7(1):9180.
doi: 10.1038/s41598-017-08889-9.

Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder

Affiliations

Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder

Su-Hyun Kim et al. Sci Rep. .

Abstract

Cognitive impairment (CI) is reported in 29-57% of patients with neuromyelitis optica spectrum disorder (NMOSD). However, the pathophysiology underlying CI in NMOSD is poorly understood. The present study aims to investigate the predictive values of various conventional and quantitative MRI parameters for cognitive performance in patients with NMOSD. Neurological assessment and conventional, diffusion tensor, and volumetric MRI sequences were collected form 73 patients with NMOSD and 44 healthy controls (HCs). Patients with ≥3 failed tests were considered to have CI. Brain lesion load, gray matter (GM) and white matter (WM) atrophy, deep GM (DGM) atrophy, cortical thickness, and diffuse microstructural WM damage were assessed. Twenty-three (32%) patients with NMOSD had CI. Compared to cognitively preserved (CP) individuals, patients with CI had atrophy in the WM, thalamus, and caudate, decreased fractional anisotropy (FA) and increased mean diffusivity in their WM. A multivariate model indicated that mean FA values in the WM and volume in the nucleus accumbens (NAc) were associated with overall cognition (p = 0.002 and p = 0.008, respectively). Diffuse microstructural damage in the WM and DGM atrophy in the NAc are the strongest predictors of cognitive impairment in patients with NMOSD.

PubMed Disclaimer

Conflict of interest statement

Kim H.J. has lectured, consulted, and received honoraria from Bayer Schering Pharma, Biogen, Genzyme, HanAll BioPharma, MedImmune, Merck Serono, Novartis, Teva-Handok, and UCB; received a grant from the Ministry of Science, ICT & Future Planning; and accepted research funding from Genzyme, Kael-GemVax, Merck Serono, Teva-Handok, and UCB; serves on a steering committee for MedImmune; is a co-editor for the Multiple Sclerosis Journal – Experimental, Translational, and Clinical, and an associated editor for the Journal of Clinical Neurology. All other authors declare that they have no competing interests.

References

    1. Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–189. doi: 10.1212/WNL.0000000000001729. - DOI - PMC - PubMed
    1. Lennon VA, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112. doi: 10.1016/S0140-6736(04)17551-X. - DOI - PubMed
    1. Vanotti S, et al. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Arq. Neuropsiquiatr. 2013;71:357–361. doi: 10.1590/0004-282X20130038. - DOI - PubMed
    1. Kim SH, et al. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis. Mult. Scler. 2016;22:1850–1858. doi: 10.1177/1352458516636246. - DOI - PubMed
    1. Blanc F, et al. Cognitive functions in neuromyelitis optica. Arch. Neurol. 2008;65:84–88. - PubMed

Publication types